Prevention of allergic eye disease by treatment with IL-1 receptor antagonist

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 12, 1999, Pages 3041-3046

  Keane Myers, Andrea M ^a,b   Miyazaki, Dai ^a   Liu, Grace ^a   Dekaris, Iva ^a   Ono, Santa ^a   Reza Dana, M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; EOSINOPHIL; EYE DISEASE; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MALE; MAST CELL; NONHUMAN; PHOTOSENSITIVITY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ALLERGENS; ANIMALS; CHEMOKINES; CONJUNCTIVITIS, ALLERGIC; GLYCOPROTEINS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LYMPH NODES; MAST CELLS; MICE; MICE, INBRED A; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 0032712880     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Friedlaender MH. Conjunctivitis of allergic origin: clinical presentation and differential diagnosis. Surv Ophthalmol. 1993;38:105-114.
2. Bond JF, Brauer AW, Segal DB, Nault AK, Rogers BL, Kuo M-C. Native and recombinant Fel d1 as probes into the relationship of allergen structure to human IgE immunoreactivity. Mol Immunol. 1993;30:1529-1541.
3. Dinarello C. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147.
4. Dana MR, Zhu S-N, Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 1998;17: 403-409.
5. Li X-M, Huang C-K, Schofield BH, et al. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J Immunol. 1999;162:3045-3052.
6. Sozzani S, Allavena P, D'Amico G, et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol. 1998;161:1083-1086.
7. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse model of asthma. J Exp Med. 1996; 183:195-201.
8. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675-705.
9. Terada N, Maesako K, Hamano N, et al. Eosinophil adhesion regulates RANTES production in nasal epithelial cells. J Immunol. 1997;158:5464-5470.
10. Garcia-Zepeda E, Rothenberg M, Ownbey R, Celestin J, Leder P, Luster A. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia. Nat Med. 1996;2:449-456.